Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(3-(5-(4-bromo-2-fluorophenylamino)-3-cyclopropyl-8-methyl-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido(2,3-d)pyrimidin-1-yl)phenyl)methanesulfonamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-(3-(5-(4-bromo-2-fluorophenylamino)-3-cyclopropyl-8-methyl-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido(2,3-d)pyrimidin-1-yl)phenyl)methanesulfonamide
Unique ID
C553329
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C553329
Entry Term(s)
JTP 70902
JTP-70902
JTP70902
Registry Numbers
SD93UQD78T
Heading Mapped to
*Pyrimidinones
*Sulfonamides
Frequency
1
Note
a protein kinase inhibitor and antineoplastic agent; structure in first source
Source
Cancer Sci 2007 Nov;98(11):1809-16
Date of Entry
2010/11/09
Revision Date
2019/01/10
N-(3-(5-(4-bromo-2-fluorophenylamino)-3-cyclopropyl-8-methyl-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido(2,3-d)pyrimidin-1-yl)phenyl)methanesulfonamide Preferred
JTP 70902 Narrower
page delivered in 0.007s